October 15th 2025, 3:00pm
The FDA granted fast track designation to NG-350A for the treatment of patients with mismatch repair-proficient locally advanced rectal cancer.
October 15th 2025, 1:00pm
A study found exercise after treatment boosts cancer survival, prompting experts to call for structured movement as a standard part of survivorship care.
October 14th 2025, 9:00pm
Patients with advanced renal cell carcinoma whose disease has progressed on first-line therapies may benefit from the combination of Fruzaqla and Tyvyt.
October 14th 2025, 8:00pm
Patients living with myelofibrosis who also experience anemia may see meaningful improvements in blood counts when treated with Vonjo.
October 14th 2025, 7:00pm
Dr. Anjana Pillai highlights Liver Cancer Awareness Month’s role in promoting liver health, dispelling myths and encouraging early detection and care.
October 14th 2025, 5:00pm
Thoughts on life, multiple myeloma, architecture and Douglas Adams.
October 14th 2025, 4:00pm
CURE spoke with Betsy Hamlin, who was treated with Keytruda Qlex in a clinical trial after being diagnosed with melanoma.
October 14th 2025, 3:00pm
The FDA granted breakthrough therapy designation to sonrotoclax for adults with relapsed or refractory mantle cell lymphoma, based on phase 1/2 data.
October 14th 2025, 1:00pm
Dr. Komal Jhaveri says Breast Cancer Awareness Month should move beyond pink ribbons to drive early detection, research and equitable care.
October 13th 2025, 9:00pm
I was sitting in my oncologist's office, listening to her explain my treatment plan, when a strange thought crossed my mind: this feels familiar.
Pancreatic Cancer on the Rise Among Younger Adults
Covering Every FDA Oncology Approval From October 2025
Why ‘There is Hope’ For Patients With Pancreatic Cancer
Walking Through It All: Staying Active With Cancer and Knee Surgery